In vivo function of the murid herpesvirus-4 ribonucleotide reductase small subunit

Journal of General Virology

Volumn 92, Issue 7, 2011, Pages 1550-1560

  Milho, Ricardo ^a   Gill, Michael B ^a   May, Janet S ^a   Colaco, Susanna ^a   Stevenson, Philip G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT; RIBONUCLEOTIDE REDUCTASE SMALL SUBUNIT; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HERPES VIRUS; HISTOLOGY; IN VIVO STUDY; INOCULATION; MURID HERPESVIRUS 4; NERVE CELL; NEUROEPITHELIUM; NONHUMAN; NUCLEOTIDE METABOLISM; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; UPPER RESPIRATORY TRACT INFECTION; VIRUS ENTRY; VIRUS REACTIVATION;

ANIMALS; CELL LINE; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; MICE; MICE, INBRED BALB C; PROTEIN SUBUNITS; RHADINOVIRUS; RIBONUCLEOTIDE REDUCTASES; VIRAL PROTEINS; VIRUS REPLICATION;

HERPESVIRIDAE; MURID HERPESVIRUS 4;

EID: 79959299038     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.031542-0     Document Type: Article

References (43)

1. Adler, H., Messerle, M., Wagner, M. & Koszinowski, U. H. (2000). Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74, 6964-6974.
2. Ator, M. A., Stubbe, J. & Spector, T. (1986). Mechanism of ribonucleotide reductase from herpes simplex virus type 1. Evidence for 39 carbon-hydrogen bond cleavage and inactivation by nucleotide analogs. J Biol Chem 261, 3595-3599.
3. Brune, W., Ménard, C., Heesemann, J. & Koszinowski, U. H. (2001). A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291, 303-305.
4. Cameron, J. M., McDougall, I., Marsden, H. S., Preston, V. G., Ryan, D. M. & Subak-Sharpe, J. H. (1988). Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol 69, 2607-2612.
5. Coen, D. M., Kosz-Vnenchak, M., Jacobson, J. G., Leib, D. A., Bogard, C. L., Schaffer, P. A., Tyler, K. L. & Knipe, D. M. (1989). Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A 86, 4736-4740.
6. Coleman, H. M., de Lima, B., Morton, V. & Stevenson, P. G. (2003). Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol 77, 2410-2417.
7. Conner, J., Marsden, H. & Clements, J. B. (1994). Ribonucleotide reductase of herpes viruses. Rev Med Virol 4, 25-34.
8. Darby, G. (1993). The acyclovir legacy: its contribution to antiviral drug discovery. J Med Virol 41 (Suppl. 1), 134-138.
9. Davison, A. J. & Stow, N. D. (2005). New genes from old: redeployment of dUTPase by herpesviruses. J Virol 79, 12880-12892.
10. de Lima, B. D., May, J. S. & Stevenson, P. G. (2004). Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol 78, 5103-5112.
11. Efstathiou, S., Kemp, S., Darby, G. & Minson, A. C. (1989). The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol 70, 869-879.
12. Faulkner, G. C., Krajewski, A. S. & Crawford, D. H. (2000). The ins and outs of EBV infection. Trends Microbiol 8, 185-189.
13. Ganem, D. (2006). KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1, 273-296.
14. Gaspar, M., Gill, M. B., Lösing, J. B., May, J. S. & Stevenson, P. G. (2008). Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS ONE 3, e2781.
15. Gill, M. B., Murphy, J. E. & Fingeroth, J. D. (2005). Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion. J Virol 79, 14647-14659.
16. Gill, M. B., Wright, D. E., Smith, C. M., May, J. S. & Stevenson, P. G. (2009). Murid herpesvirus-4 lacking thymidine kinase reveals routedependent requirements for host colonization. J Gen Virol 90, 1461-1470.
17. Gill, M. B., May, J. S., Colaco, S. & Stevenson, P. G. (2010). Important role for the murid herpesvirus 4 ribonucleotide reductase large subunit in host colonization via the respiratory tract. J Virol 84, 10937-10942.
18. Gillet, L., May, J. S., Colaco, S. & Stevenson, P. G. (2007). The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS ONE 2, e705.
19. Gustafson, E. A., Chillemi, A. C., Sage, D. R. & Fingeroth, J. D. (1998). The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob Agents Chemother 42, 2923-2931.
20. Hoagland, R. J. (1964). The incubation period of infectious mononucleosis. Am J Public Health Nations Health 54, 1699-1705.
21. Hoshino, Y., Katano, H., Zou, P., Hohman, P., Marques, A., Tyring, S. K., Follmann, D. & Cohen, J. I. (2009). Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers. J Virol 83, 11857-11861.
22. Hutt-Fletcher, L. M. (2007). Epstein-Barr virus entry. J Virol 81, 7825-7832.
23. Jacobson, J. G., Leib, D. A., Goldstein, D. J., Bogard, C. L., Schaffer, P. A., Weller, S. K. & Coen, D. M. (1989). A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology 173, 276-283.
24. Jordan, A. & Reichard, P. (1998). Ribonucleotide reductases. Annu Rev Biochem 67, 71-98.
25. Kayhan, B., Yager, E. J., Lanzer, K., Cookenham, T., Jia, Q., Wu, T. T., Woodland, D. L., Sun, R. & Blackman, M. A. (2007). A replicationdeficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity. J Immunol 179, 8392-8402.
26. Langelier, Y., Bergeron, S., Chabaud, S., Lippens, J., Guilbault, C., Sasseville, A. M., Denis, S., Mosser, D. D. & Massie, B. (2002). The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J Gen Virol 83, 2779-2789.
27. Milho, R., Smith, C. M., Marques, S., Alenquer, M., May, J. S., Gillet, L., Gaspar, M., Efstathiou, S., Simas, J. P. & Stevenson, P. G. (2009). In vivo imaging of murid herpesvirus-4 infection. J Gen Virol 90, 21-32.
28. Moorman, N. J., Lin, C. Y. & Speck, S. H. (2004). Identification of candidate gammaherpesvirus 68 genes required for virus replication by signature-tagged transposon mutagenesis. J Virol 78, 10282-10290.
29. Moser, J. M., Farrell, M. L., Krug, L. T., Upton, J. W. & Speck, S. H. (2006). A gammaherpesvirus 68 gene 50 null mutant establishes longterm latency in the lung but fails to vaccinate against a wild-type virus challenge. J Virol 80, 1592-1598.
30. Pica, F. & Volpi, A. (2007). Transmission of human herpesvirus 8: an update. Curr Opin Infect Dis 20, 152-156.
31. Pontarin, G., Fijolek, A., Pizzo, P., Ferraro, P., Rampazzo, C., Pozzan, T., Thelander, L., Reichard, P. A. & Bianchi, V. (2008). Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc Natl Acad Sci U S A 105, 17801-17806.
32. Rawlinson, W. D., Farrell, H. E. & Barrell, B. G. (1996). Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70, 8833-8849.
33. Shannon-Lowe, C., Adland, E., Bell, A. I., Delecluse, H. J., Rickinson, A. B. & Rowe, M. (2009). Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 83, 7749-7760.
34. Song, M. J., Hwang, S., Wong, W. H., Wu, T. T., Lee, S., Liao, H. I. & Sun, R. (2005). Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc Natl Acad Sci U S A 102, 3805-3810.
35. Stevenson, P. G., May, J. S., Smith, X. G., Marques, S., Adler, H., Koszinowski, U. H., Simas, J. P. & Efstathiou, S. (2002). K3-mediated evasion of CD8+ T cells aids amplification of a latent gammaherpesvirus. Nat Immunol 3, 733-740.
36. Stevenson, P. G., Simas, J. P. & Efstathiou, S. (2009). Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4. J Gen Virol 90, 2317-2330.
37. Terry, L. A., Stewart, J. P., Nash, A. A. & Fazakerley, J. K. (2000). Murine gammaherpesvirus-68 infection of and persistence in the central nervous system. J Gen Virol 81, 2635-2643.
38. Tibbetts, S. A., Suarez, F., Steed, A. L., Simmons, J. A. & Virgin, H. W., IV (2006). A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells. Virology 353, 210-219.
39. Upton, J. W., Kaiser, W. J. & Mocarski, E. S. (2010). Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7, 302-313.
40. Virgin, H. W., IV, Latreille, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J. & Speck, S. H. (1997). Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71, 5894-5904.
41. Wnuk, S. F. & Robins, M. J. (2006). Ribonucleotide reductase inhibitors as anti-herpes agents. Antiviral Res 71, 122-126.
42. Yamada, Y., Kimura, H., Morishima, T., Daikoku, T., Maeno, K. & Nishiyama, Y. (1991). The pathogenicity of ribonucleotide reductasenull mutants of herpes simplex virus type 1 in mice. J Infect Dis 164, 1091-1097.
43. Yao, Q. Y., Ogan, P., Rowe, M., Wood, M. & Rickinson, A. B. (1989). Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int J Cancer 43, 67-71.